Revolutionizing Cancer Care
Kiyatec (kiyatec.com) scores 74 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 38th percentile of 13187 Healthcare brands.
Kiyatec is a biotechnology company based in Greenville, United States, founded in 2005. It develops predictive, patient-specific 3D cell culture technology designed to forecast individual cancer patients' responses to treatment before therapy begins. The company aims to help clinicians avoid ineffective therapies and improve patient outcomes by providing pre-treatment response predictions. Its work targets oncologists, cancer treatment centers, pharmaceutical companies, and patients seeking personalized treatment insights, positioning Kiyatec within the broader healthcare and precision oncology space.
| Brand Name | Kiyatec |
|---|---|
| Domain | kiyatec.com |
| Industry | Healthcare |
| Founded | 2005 |
| Headquarters | Greenville, United States |
| Main Competitors | Champions Oncology (78/100), SEngine Precision Medicine, Notable Labs, Cellworks Group, Predictive Oncology |
Moz Domain Authority 33/100 vs category average 41 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Kiyatec is disrupting cancer care by accurately predicting patient-specific response and non-response before treatment begins." (Meta description: 15 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, + Microdata, og:title, og:description, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, X (Twitter), Instagram, YouTube; no detected presence on Facebook, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Kiyatec?", Claude could identify the brand as of September 2026. KIYATEC is a precision medicine company that uses 3D cell culture technology, specifically patient-derived tumor organoids, to predict how individual cancer patients will respond to specific treatments before those treatments are administered. Their platform is aimed at helping o Best known for 3D tumor organoid technology for predicting individual patient response to cancer therapies.
When asked "Best brands similar to Kiyatec?", Claude would recommend Kiyatec as of September 2026. If someone asked about functional precision oncology or tumor organoid companies, KIYATEC is a legitimate and relevant name to bring up given their focus on patient-derived 3D culture models for treatment response prediction.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Kiyatec has limited AI-search visibility, scoring 36/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 47, recommendation 48). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Kiyatec official site
Kiyatec was founded in 2005. Kiyatec operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Kiyatec scores 48/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Kiyatec official site
Kiyatec is a biotechnology company headquartered in Greenville, United States, founded in 2005. It focuses on predictive, personalized cancer diagnostics using 3D cell culture technology to forecast how individual patients will respond to treatment before therapy begins.
Sources: Kiyatec official site
Kiyatec develops and applies predictive, patient-specific 3D cell culture technology that models how a cancer patient's tumor cells will respond to specific treatments. This allows clinicians to predict treatment response or non-response before therapy starts, aiming to help avoid ineffective treatments and improve patient outcomes.
Sources: Kiyatec official site
Kiyatec can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Kiyatec official site
Kiyatec offers predictive, patient-specific 3D cell culture technology used to forecast how individual cancer patients will respond to specific treatments before therapy begins. This technology is intended for use by oncologists, cancer treatment centers, and pharmaceutical companies to inform personalized treatment decisions.
Sources: Kiyatec official site
Kiyatec is known for its 3D cell culture-based predictive diagnostic technology that forecasts individual cancer patients' responses to treatment prior to starting therapy, positioning it as a pioneer in personalized, predictive oncology diagnostics.
Sources: Kiyatec official site
Kiyatec's technology is intended for use by oncologists, cancer treatment centers, pharmaceutical companies, and cancer patients seeking personalized, predictive insights into how they will respond to specific cancer treatments before starting therapy.
Sources: Kiyatec official site
Kiyatec scores 36/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Kiyatec has a weak AI-visibility profile at 36/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (48/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry, open access for AI crawlers (GPTBot, ClaudeBot, etc.) and machine-readable schema.org markup. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 33/100 and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Kiyatec from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Kiyatec: 한국과학기술연구원 (KIST) (74/100), Kirby Bates Associates (74/100), KLD Biosistemas (74/100), KNMvD (74/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.